We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+6.35%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$25.5B
AUM Growth
+$1.27B
Cap. Flow
+$15.7M
Cap. Flow %
0.06%
Top 10 Hldgs %
11.03%
Holding
2,244
New
814
Increased
508
Reduced
495
Closed
411

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$249M
2
GS icon
Goldman Sachs
GS
+$228M
3
BABA icon
Alibaba
BABA
+$162M
4
CX icon
Cemex
CX
+$157M
5
HAL icon
Halliburton
HAL
+$155M

Sector Composition

Rank Sector Weight
1 Financials 20.11%
2 Consumer Discretionary 12.23%
3 Healthcare 10.85%
4 Technology 7.76%
5 Real Estate 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PII icon
2051
CALL
Polaris
PII
$3.66B
-50,000
Closed -$4.61M
PK icon
2052
Park Hotels & Resorts
PK
$3.18B
-312,051
Closed -$8.41M
PLNT icon
2053
Planet Fitness
PLNT
$4.09B
-1,019,787
Closed -$23.8M
PNC icon
2054
PNC Financial Services
PNC
$97B
-7,334
Closed -$941K
PNFP icon
2055
Pinnacle Financial Partners Inc
PNFP
$15.5B
-3,900
Closed -$245K
PPC icon
2056
Pilgrim's Pride
PPC
$7.68B
-789,357
Closed -$17.3M
PR
2057
Permian Resources
PR
$19.9B
-908,730
Closed -$14.4M
PSX icon
2058
Phillips 66
PSX
$96.9B
-11,700
Closed -$967K
RARE icon
2059
Ultragenyx Pharmaceutical
RARE
$2.55B
-7,700
Closed -$478K
RCL icon
2060
PUT
Royal Caribbean
RCL
$78.1B
-100,000
Closed -$10.9M
REGN icon
2061
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
-365,000
Closed -$179M
REGN icon
2062
Regeneron Pharmaceuticals
REGN
$85.9B
-58,357
Closed -$28.7M
RHI icon
2063
CALL
Robert Half
RHI
$4.58B
-100,000
Closed -$4.79M
RHI icon
2064
Robert Half
RHI
$4.58B
-200,552
Closed -$9.61M
RIG icon
2065
Transocean
RIG
$6.61B
-10,115
Closed -$83K
RITM icon
2066
Rithm Capital
RITM
$5.69B
-16,300
Closed -$254K
RNST icon
2067
Renasant Corp
RNST
$3.79B
-144,236
Closed -$6.31M
RSG icon
2068
Republic Services
RSG
$67.6B
-16,524
Closed -$1.05M
RVTY icon
2069
Revvity
RVTY
$13.9B
-3,975
Closed -$271K
SABR icon
2070
CALL
Sabre
SABR
$848M
-200,000
Closed -$4.35M
SBAC icon
2071
SBA Communications
SBAC
$19.4B
-2,300
Closed -$310K
SBSW icon
2072
Sibanye-Stillwater
SBSW
$8.9B
-54,172
Closed -$236K
SBUX icon
2073
CALL
Starbucks
SBUX
$122B
-1,050,000
Closed -$61.2M
SHW icon
2074
Sherwin-Williams
SHW
$84.1B
-5,964
Closed -$698K
SIMO icon
2075
Silicon Motion
SIMO
$8.76B
-137,292
Closed -$6.62M

Similar funds

Dmitry Balyasny's Q3 2017 Portfolio in Review

As of Q3 2017, Dmitry Balyasny held 2,244 positions worth $25.5B, up 5.2% from $24.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Dmitry Balyasny's Q3 2017 filing shows 814 new, 508 increased, 495 reduced and 411 closed positions. Its largest new stake was Range Resources: 5,316,064 shares worth $104M. The largest sale was Bank of America, an estimated $249M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Dmitry Balyasny's largest Q3 2017 buy was Range Resources: 5,316,064 shares worth $104M.
  • Dmitry Balyasny added most to JPMorgan Chase in Q3 2017, an estimated $371M increase.
  • Dmitry Balyasny's biggest Q3 2017 reduction was Bank of America, cutting an estimated $249M.
  • Dmitry Balyasny fully exited Cemex in Q3 2017, selling an estimated $157M.
  • Dmitry Balyasny's ten largest holdings make up 11% of its $25.5B portfolio in Q3 2017.
  • Dmitry Balyasny opened 814 new positions and closed 411 in Q3 2017.
  • Dmitry Balyasny's portfolio value rose 5.2% quarter-over-quarter to $25.5B.

Based on Balyasny Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.